Velaglucerase Alfa (VPRIV) Enzyme Replacement Therapy in Velaglucerase Alfa (VPRIV) Enzyme Replacement Therapy in Patients with Gaucher Disease: Long-Term Data from Phase III Patients with Gaucher Disease: Long-Term Data from Phase III Clinical Trials Clinical Trials
暂无分享,去创建一个
T. Hangartner | M. Kabra | A. Bavdekar | D. Elstein | Nan Wang | E. Crombez | D. Gonzalez | Atul Mehta | I. Kisinovsky | Pilar Giraldo | D. Hughes | Elena A. Lukina | Ari Zimran